Extraction of ofloxacin from water using hydrophobic eutectic solvents

resumo

Wastewater treatment plants do not cope well with emerging micropollutants, such as pharmaceuticals, because they are not effective to remove them. Therefore, this work aims to develop a process for the extraction of ofloxacin (OFX) based on a liquid -liquid extraction using hydrophobic eutectic solvents (HES), coupled with the Conductor -like Screening Model for Real Solvent (COSMO-RS) for solvent screening. First, COSMO-RS was used to predict the partition coefficient of OFX for four HES families: L -menthol: fatty acid, L -menthol: fatty alcohol, fatty acid: fatty acid and fatty acid: fatty alcohols, at three different molar ratios (2:1, 1:1, and 1:2). These results showed that HES formed by fatty acids, especially those with a longer alkyl chain and a higher fatty acid molar ratio, were the most suitable solvents for OFX extraction. Then, the most promising HES to extract OFX was evaluated experimentally. The HES decanoic acid: dodecanoic acid (C10 acid: C12 acid) in a molar ratio of 2:1 being the system with best extraction results of OFX was selected to optimize the extraction conditions of OFX, namely pH, HES: water ratio (v/v), and OFX concentration, using a response surface methodology (RSM). The results obtained showed that at a pH of 5.2, HES-water ratio (v/v) of 1.3, and 2.5 mg/ml of OFX that an extraction efficiency of OFX of (98.8 +/- 0.9)% could be achieved. The results show that one-step OFX extraction is possible, but is significantly influenced by both the extraction parameters and the hydrophobic properties of the HES.

palavras-chave

PARTITION-COEFFICIENTS; WASTE-WATER; COSMO-RS; TREATMENT PLANTS; ANTIBIOTICS; PREDICTION; DEGRADATION; TOXICITY; REMOVAL

categoria

Engineering

autores

Moradi, M; Ferreira, AM; Neves, CMSS; Mahmoudabadi, SZ; Pazuki, G; Coutinho, JAP

nossos autores

agradecimentos

This work was developed partly within the scope of the project CICECO-Aveiro Institute of Materials, UIDB/50011/2020 (DOI 10.54499/UIDB/50011/2020), UIDP/50011/2020 (DOI 10.54499/UIDP/50011/2020) & LA/P/0006/2020 (DOI 10.54499/LA/P/0006/2020) , financed by national funds through the FCT/MCTES (PIDDAC) . AMF and CSSN acknowledge FCT for the research contracts CEECIND/00361/2022 (DOI 10.54499/2022.00361.CEECIND/CP1720/CT0020) and CEECIND/01975/2017 (DOI 10.54499/CEECIND/01975/2017/CP1459/CT0037) under the Scientific Stimulus - Individual Call, respectively. The authors would like to sincerely thank the Iran Biotech Fund for their financial support with grant number 13951.

Partilhe este projeto

Publicações similares

Usamos cookies para atividades de marketing e para lhe oferecer uma melhor experiência de navegação. Ao clicar em “Aceitar Cookies” você concorda com nossa política de cookies. Leia sobre como usamos cookies clicando em "Política de Privacidade e Cookies".